The ALS Association/Northeast ALS Consortium PALS Webinar
REFINE-ALS: A Much Needed Biomarker Study of Edaravone (Radicava) in ALS
James D. Berry, MD, MPH, Massachusetts General Hospital
Thursday, November 14, 2019
4:00 - 5:00 PM EST
We will review edaravone evidence, talk about the use of biomarkers to understand the effect of medical therapies, present the design of the REFINE-ALS study, and discuss how people can get involved in the study.
